CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis.
about
EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against CancerTh17 Cells in Protection from Tumor or Promotion of Tumor ProgressionMouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.Tumor-associated neutrophils suppress pro-tumoral IL-17+ γδ T cells through induction of oxidative stress.Dietary Supplementation of Selenoneine-Containing Tuna Dark Muscle Extract Effectively Reduces Pathology of Experimental Colorectal Cancers in Mice
P2860
CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CD11b+Ly6G+ cells inhibit tumo ...... early stages of tumorigenesis.
@en
type
label
CD11b+Ly6G+ cells inhibit tumo ...... early stages of tumorigenesis.
@en
prefLabel
CD11b+Ly6G+ cells inhibit tumo ...... early stages of tumorigenesis.
@en
P2093
P2860
P1433
P1476
CD11b+Ly6G+ cells inhibit tumo ...... early stages of tumorigenesis.
@en
P2093
Claire E O'Leary
G Scott Worthen
Junjie Mei
Liang-Chuan S Wang
Paula M Oliver
Peihui Liu
Steven M Albelda
Tricia R Bhatti
P2860
P304
P356
10.1080/2162402X.2015.1061175
P577
2015-07-28T00:00:00Z